Age-related properties of the tumour vasculature in renal cell carcinoma

BJU International

Volumn 107, Issue 3, 2011, Pages 416-424

  Meehan, Brian ^a   Appu, Sree ^b   St Croix, Brad ^c   Rak Poznanska, Krystyna ^d   Klotz, Laurence ^a   Rak, Janusz ^b  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Provincial Specialistic Hospital   (Poland)

Author keywords

ageing; angiogenesis; arteriogenesis; endothelial nitric oxide synthase; RCC

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CD45 ANTIGEN; DELTA LIKE 1; DELTA LIKE 4; ENDOSIALIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; NOTCH RECEPTOR; TUMOR ENDOTHELIAL MARKER 7; TUMOR ENDOTHELIAL MARKER 8; TUMOR MARKER; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; AGING; ANGIOGENESIS; ARTICLE; CAPILLARY DENSITY; CELL DIVISION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LEUKOCYTE; MALE; METASTASIS POTENTIAL; PERICYTE; PILOT STUDY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; CARCINOMA, RENAL CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC;

EID: 79251555978     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09569.x     Document Type: Article

References (55)

1. Folkman J, Kalluri R,. Chapt 11: Tumor angiogenesis. In, Kufe DW, Pollock RE, Weichselbaum RR, et al. eds. Cancer Medicine, 6th edn. Hamilton, London: BC Decker Inc., 2003: 161-94
2. Kerbel RS,. Tumor angiogenesis. N Engl J Med 2008; 358 (19): 2039-49
3. Ferrara N, Hillan KJ, Gerber HP, Novotny W,. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004; 3 (5): 391-400
4. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993; 143: 1255-62 (Pubitemid 24057094)
5. Kaelin WG Jr,. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 2008; 8 (11): 865-73
6. Rini BI,. Metastatic renal cell carcinoma: many treatment options, one patient. J Clin Oncol 2009; 27 (19): 3225-34
7. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356 (2): 125-34
8. Dutcher JP, Tannir N, Bellmunt J, Escudier B,. Experience with sorafenib and the elderly patient. Med Oncol 2009 [Epub ahead of print]
9. Eremina V, Baelde HJ, Quaggin SE,. Role of the VEGF-a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007; 106 (2): 32-7
10. Schoenfeld J, Lessan K, Johnson NA, et al. Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF. Angiogenesis 2004; 7 (2): 143-56
11. Carmeliet P,. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6 (4): 389-95
12. Limbourg A, Ploom M, Elligsen D, et al. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circ Res 2007; 100 (3): 363-71
13. Thurston G, Noguera-Troise I, Yancopoulos GD,. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer 2007; 7 (5): 327-31
14. Jones EA, le Noble F, Eichmann A,. What determines blood vessel structure? Genetic prespecification vs. hemodynamics. Physiology 2006; 21: 388-95
15. Scholz D, Cai WJ, Schaper W,. Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 2001; 4 (4): 247-57
16. Searles CD,. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol 2006; 291 (5): C803-16
17. Ying L, Hofseth LJ,. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 2007; 67 (4): 1407-10
18. Sun S, Du R, Gao J, et al. Expression and clinical significance of Notch receptors in human renal cell carcinoma. Pathology 2009; 41 (4): 335-41
19. Patel NS, Li JL, Generali D, Poulsom R, Cranston DW, Harris AL,. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 2005; 65 (19): 8690-7
20. Weidner N, Semple JP, Welch WR, Folkman J,. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8
21. Imao T, Egawa M, Takashima H, Koshida K, Namiki M,. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma. Int J Urol 2004; 11 (11): 948-53
22. Rohan RM, Fernandez A, Udagawa T, Yuan J, D'Amato RJ,. Genetic heterogeneity of angiogenesis in mice. FASEB J 2000; 14 (7): 871-6
23. Lyden D, Young AZ, Zagzag D, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999; 401 (6754): 670-7
24. Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY,. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int 2008; 101 (6): 758-64
25. Long DA, Mu W, Price KL, Johnson RJ,. Blood vessels and the aging kidney. Nephron Exp Nephrol 2005; 101 (3): e95-9
26. Reed MJ, Edelberg JM,. Impaired angiogenesis in the aged. Sci Aging Knowledge Environ 2004; 2004 (7): e7
27. Rivard A, Berthou-Soulie L, Principe N, et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 2000; 275 (38): 29643-7
28. Pili R, Guo Y, Chang J, Nakanishi H, Martin GR, Passaniti A,. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 1994; 86 (17): 1303-14
29. Franco S, Segura I, Riese HH, Blasco MA,. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res 2002; 62 (2): 552-9
30. Shimada T, Takeshita Y, Murohara T, et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004; 110 (9): 1148-55
31. Klement H, St Croix B, Milsom C, et al. Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy. Am J Pathol 2007; 171 (4): 1342-51
32. Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008; 10 (5): 619-24
33. Delahunt B, Bethwaite PB, Thornton A,. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol 1997; 80 (3): 401-4
34. Yu JL, Rak JW,. Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res 2003; 5 (2): 83-8
35. St.Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science 2000; 289 (5482): 1197-202
36. Neri D, Bicknell R,. Tumour vascular targeting. Nat Rev Cancer 2005; 5 (6): 436-46
37. Christian S, Winkler R, Helfrich I, et al. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008; 172 (2): 486-94
38. Bagley RG, Rouleau C, St Martin T, et al. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Mol Cancer Ther 2008; 7 (8): 2536-46
39. Prior BM, Lloyd PG, Ren J, et al. Arteriogenesis: role of nitric oxide. Endothelium 2003; 10 (4-5): 207-16
40. Cai W, Schaper W,. Mechanisms of arteriogenesis. Acta Biochim Biophys Sin 2008; 40 (8): 681-92
41. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108 (4): 457-63
42. Xu Q,. The impact of progenitor cells in atherosclerosis. Nat Clin Pract Cardiovasc Med 2006; 3 (2): 94-101
43. Yoshino S, Kato M, Okada K,. Evaluation of the prognostic significance of microvessel count and tumor size in renal cell carcinoma. Int J Urol 1998; 5 (2): 119-23
44. Nativ O, Sabo E, Reiss A, Wald M, Madjar S, Moskovitz B,. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology 1998; 51 (5): 693-6
45. Edeline J, Rioux-Leclercq N,. Renal cell carcinoma and prognostic factors. Ann Pathol 2008; 28 (5): 374-80
46. Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB,. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 2001; 7 (3): 533-7
47. MacLennan GT, Bostwick DG,. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 1995; 46 (1): 27-30
48. Gelb AB, Sudilovsky D, Wu CD, Weiss LM, Medeiros LJ,. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma. Cancer 1997; 80 (9): 1768-75
49. Okon K, Kawa R,. Microvascular network in renal carcinomas. Quantitative and tissue microarray immunohistochemical study. Pol J Pathol 2008; 59 (2): 107-15
50. Yao X, Qian CN, Zhang ZF, et al. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res 2007; 13 (1): 161-9
51. Vroling L, van der Veldt AA, de Haas RR, et al. Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib. Angiogenesis 2009; 12 (1): 69-79
52. Yilmazer D, Han U, Onal B,. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma. Int Urol Nephrol 2007; 39 (3): 691-8
53. Ershler WB, Moore AL, Shore H, Gamelli RL,. Transfer of age-associated restrained tumor growth in mice by old-to-young bone marrow transplantation. Cancer Res 1984; 44 (12 Pt 1): 5677-80
54. Balducci L, Ershler WB,. Cancer and ageing: A nexus at several levels. Nat Rev Cancer 2005; 5 (8): 655-62
55. Sprenger CC, Plymate SR, Reed MJ,. Extracellular influences on tumour angiogenesis in the aged host. Br J Cancer 2008; 98 (2): 250-5